Abbott India

Update in progress

ABBOTINDIA.NS (NSE)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Abbott India Limited and its subsidiaries operate as a pharmaceutical company in India. It offers products across gastroenterology, women’s health, metabolic and central nervous system disorders, vaccines and multispecialty care, including insomnia, vitamin D deficiency, pre-term labor and pain management. The portfolio also covers anti-infectives, cardio-metabolic, GI and hepatology, hormones, neuropsychiatry, respiratory, neuroscience, metabolics and consumer care. Formerly Knoll Pharmaceuticals, it was renamed in 2002. Founded in 1910, it is based in Mumbai and is a subsidiary of Abbott Capital India Limited.

Company score

Sentiment: 0.16; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.00; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.03; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -0.01; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.08; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive